Kesavan Esuvaranathan

Esuvaranathan Kesavan

Appointment(s)
  • Professor, Department of Surgery
  • Senior Consultant, Department of Urology, University Surgical Cluster, National University Health System
Administrative Appointment(s)
  • Vice Chairman, Medical Board (Surgical Strategies), Department of Urology, University Surgical Cluster, National University Health System
  • Clinical Director, Urology Centre, University Surgical Cluster, National University Health System
  • Leader, Prostate/Urology Tumour Group, National University Cancer Institute, Singapore, National University Health System
Academic Qualifications
  • MBBS, National University of Singapore, Singapore
  • MD, National University of Singapore, Singapore
  • FRCSEd, Royal College of Surgeons of Edinburgh, United Kingdom
  • FRCSG, Royal College of Physicians and Surgeons of Glasgow, United Kingdom
  • FAMS, Academy of Medicine, Singapore
Research Interest(s)
  • Bladder Cancer
  • Immunotherapy |Metabolomics
  • Gene Therapy
  • Prostate Cancer
Recent Publications
  • 1. Rahmat, J. N., Esuvaranathan, K., & Mahendran, R. (2018). Bacillus Calmette-GuĂ©rin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival. Oncology Letters, 15(6), 9231-9241. doi:10.3892/ol.2018.8462
  • 2. Tham, S. M., Esuvaranathan, K., & Mahendran, R. (2017). A Murine Orthotopic Bladder Tumor Model and Tumor Detection System. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, (119), 12 pages. doi:10.3791/55078
  • 3. Esuvaranathan, K. (2016). Editorial comments on: Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder, by E. Kaasinen etal. (in this issue). SCANDINAVIAN JOURNAL OF UROLOGY, 50(5), 369. doi:10.1080/21681805.2016.1217559
  • 4. Ang, W. X., Zhao, Y., Kwang, T., Wu, C., Chen, C., Toh, H. C., . . . Wang, S. (2016). Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy. SCIENTIFIC REPORTS, 6, 12 pages. doi:10.1038/srep27455
  • 5. Hong, Y., Esuvaranathan, K., Pasikanti, K. K., & Chan, E. C. Y. (2015). Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?. BIOANALYSIS, 7(21), 2727-2729. doi:10.4155/bio.15.192